Our stratification analyses also showed that the responses to α-ADR and β-ADR blocker treatment in patients with essential hypertension (stratified according to RGS2 [-391, C>G] genotypes) were age- and genotype-dependent; these results are summarized in Table 3. This evidence concerns the gene RGS2 and essential hypertension.